OmniAb (OABI) Other Operating Expenses (2021 - 2026)
OmniAb (OABI) posted quarterly Other Operating Expenses of $46000.0 for Q1 2026, down 93.87% year-over-year from $750000.0 in Q1 2025, and up 129.3% quarter-over-quarter from -$157000.0 in Q4 2025.
OmniAb (OABI) Other Operating Expenses (2021 - 2026) Analysis & Trends
OmniAb (OABI) has reported Other Operating Expenses for 6 consecutive years, with $46000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses fell 93.87% year-over-year to $46000.0; the TTM figure through Mar 2026 stood at $1.8 million (down 41.78% YoY), while the FY2025 annual figure was $2.5 million, up 7.78% from the prior year.
- Other Operating Expenses grew to $46000.0 in Q1 2026 per OABI's latest filing, from -$157000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $2.5 million in Q2 2024 and bottomed at -$165000.0 in Q2 2022.
- Historically, Other Operating Expenses has averaged $315352.9 across 5 years, with a median of $34000.0 in 2025.
- Annual changes were most pronounced in 2022 — Other Operating Expenses plunged 7651.49% — and 2024, when it surged 1902.86%.
- OmniAb's Other Operating Expenses stood at $106000.0 in 2022, then sank by 86.79% to $14000.0 in 2023, then jumped by 192.86% to $41000.0 in 2024, then slumped by 482.93% to -$157000.0 in 2025, then jumped by 129.3% to $46000.0 in 2026.
- Business Quant data shows OABI's Other Operating Expenses at $46000.0 in Q1 2026, -$157000.0 in Q4 2025, and $34000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | OmniAb | 491.42 Mn | 439.42 Mn | 12.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -150,000.00 |
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | -157,000.00 |
| Sep 30, 2025 | 34,000.00 |
| Jun 30, 2025 | 1.92 Mn |
| Mar 31, 2025 | 750,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | -146,000.00 |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | -54,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | -16,000.00 |
| Jun 30, 2023 | -140,000.00 |
| Mar 31, 2023 | -49,000.00 |
| Dec 31, 2022 | 106,000.00 |
| Sep 30, 2022 | 208,000.00 |
| Jun 30, 2022 | -165,000.00 |
| Mar 31, 2022 | 443,000.00 |
| Dec 31, 2021 | 70.18 Mn |
| Sep 30, 2021 | 170,579.00 |